Effect of stroke early supported discharge on length of hospital stay: analysis from a national stroke registry.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
20 01 2021
Historique:
entrez: 21 1 2021
pubmed: 22 1 2021
medline: 27 4 2021
Statut: epublish

Résumé

The first observational study to investigate the impact of early supported discharge (ESD) on length of hospital stay in real-world conditions. Using historical prospective Sentinel Stroke National Audit Programme (SSNAP) data (1 January 2013-31 December 2016) and multilevel modelling, cross-sectional (2015-2016; 30 791 patients nested within 55 hospitals) and repeated cross-sectional (2013-2014 vs 2015-2016; 49 266 patients nested within 41 hospitals) analyses were undertaken. Hospitals were sampled across a large geographical area of England covering the West and East Midlands, the East of England and the North of England. Stroke patients whose data were entered into the SSNAP database by hospital teams. Receiving ESD along the patient care pathway. Length of hospital stay. When adjusted for important case-mix variables, patients who received ESD on their stroke care pathway spent longer in hospital, compared with those who did not receive ESD. The percentage increase was 15.8% (95% CI 12.3% to 19.4%) for the 2015-2016 cross-sectional analysis and 18.8% (95% CI 13.9% to 24.0%) for the 2013-2014 versus 2015-2016 repeated cross-sectional analysis. On average, the increased length of hospital stay was approximately 1 day. This study has shown that by comparing ESD and non-ESD patient groups matched for important patient characteristics, receiving ESD resulted in a 1-day increase in length of hospital stay. The large reduction in length of hospital stay overall, since original trials were conducted, may explain why a reduction was not observed. The longer term benefits of accessing ESD need to be investigated further. http://www.isrctn.com/ISRCTN15568163.

Identifiants

pubmed: 33472788
pii: bmjopen-2020-043480
doi: 10.1136/bmjopen-2020-043480
pmc: PMC7818805
doi:

Banques de données

ISRCTN
['ISRCTN15568163']

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e043480

Subventions

Organisme : Department of Health
ID : 16/01/17
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ. 2014 Aug 05;349:g4757
pubmed: 25098169
BMC Neurol. 2019 Mar 12;19(1):40
pubmed: 30866844
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104996
pubmed: 32689626
Stroke. 2015 Apr;46(4):1065-70
pubmed: 25677597
Stroke. 2019 Jul;50(7):e187-e210
pubmed: 31104615
Int J Stroke. 2016 Jun;11(4):459-84
pubmed: 27079654
Stroke. 2009 Jan;40(1):24-9
pubmed: 19008473
Clin Rehabil. 2013 Aug;27(8):750-7
pubmed: 23455948
PLoS One. 2015 Jul 17;10(7):e0133536
pubmed: 26186211
Clin Rehabil. 2016 Mar;30(3):268-76
pubmed: 25828093
Clin Rehabil. 2012 Sep;26(9):771-86
pubmed: 22257504
Clin Rehabil. 2018 Aug;32(8):997-1006
pubmed: 29932011
Stroke. 2011 May;42(5):1392-7
pubmed: 21441151
Lancet. 2011 May 14;377(9778):1693-702
pubmed: 21571152
Implement Sci. 2019 Jun 13;14(1):61
pubmed: 31196123
Health Soc Care Community. 2009 Feb;17(1):45-53
pubmed: 18564193
Cochrane Database Syst Rev. 2017 Jul 13;7:CD000443
pubmed: 28703869
Clin Rehabil. 2020 May;34(5):698-709
pubmed: 32141324
Circ Cardiovasc Qual Outcomes. 2020 Aug;13(8):e006395
pubmed: 32674640
Clin Rehabil. 2014 Apr;28(4):370-7
pubmed: 24006226

Auteurs

Rebecca J Fisher (RJ)

Division of Rehabilitation, Ageing and Wellbeing, University of Nottingham, Nottingham, UK rebecca.fisher@nottingham.ac.uk.

Adrian Byrne (A)

Division of Rehabilitation, Ageing and Wellbeing, University of Nottingham, Nottingham, UK.

Niki Chouliara (N)

Division of Rehabilitation, Ageing and Wellbeing, University of Nottingham, Nottingham, UK.

Sarah Lewis (S)

Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.

Lizz Paley (L)

Department of Population Health Sciences, King's College London, London, UK.

Alex Hoffman (A)

Department of Population Health Sciences, King's College London, London, UK.

Anthony Rudd (A)

Department of Population Health Sciences, King's College London, London, UK.

Thompson Robinson (T)

Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.

Peter Langhorne (P)

Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK.

Marion Walker (M)

Division of Rehabilitation, Ageing and Wellbeing, University of Nottingham, Nottingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH